Antibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy ProtocolsBevacizumab
Dr. James Kendel Schwarz, MD
NPI1710968847PAC ID4385703453
- Medicare services, 2024
- 3,090
- Medicare patients, 2024
- 198
- Part D claims, 2024
- 450
- Publications
- 5
- Clinical trials
- 5
- Practice address
- 8303 Dodge St, Omaha, NE 68114
- Practice phone
- Call (402) 354-4000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Nebraska Methodist Hospital
Omaha, Nebraska
Find Dr. Schwarz's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. James Kendel Schwarz is a hematologist and oncologist in Omaha, Nebraska
Dr. Schwarz practices at Nebraska Methodist Hospital in Omaha, Nebraska.
Dr. Schwarz's NPI, 1710968847, was assigned on November 7, 2005. Dr. Schwarz graduated from Duke University School of Medicine in 1983. Dr. Schwarz holds Nebraska license 24854.
NPI and contact details
- NPI
- 1710968847NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4385703453
- NPI enumeration date
- November 7, 2005
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (402) 354-4000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 69
- Medical school graduation
- 1983
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. James Kendel Schwarz practices at Nebraska Methodist Hospital in Omaha, Nebraska
Dr. Schwarz's primary practice is Nebraska Methodist Hospital, at 8303 Dodge St, Omaha, NE 68114 in Douglas County. The practice phone is (402) 354-4000.
- Nebraska Methodist Hospital8303 Dodge St, Omaha, NE 68114 · Douglas CountyPhone(402) 354-4000
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. James Kendel Schwarz is affiliated with 3 sites of care and 2 medical groups
Dr. Schwarz's primary practice is Nebraska Methodist Hospital in Omaha, Nebraska. Dr. Schwarz is also affiliated with Methodist Hospital. The medical group on file is Nebraska Cancer Specialists. Dmand AI also links Dr. Schwarz to 1 more hospital and 1 medical group, each named with a free account.
Nebraska Methodist HospitalPrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. James Kendel Schwarz's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schwarz practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Nebraska Methodist Hospital | Available with a free account |
| +2 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Schwarz practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. James Kendel Schwarz is one of 80 hematologists and oncologists in Nebraska
Hematology and oncology is Dr. Schwarz's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Schwarz's licenses on file in 2 states: Nebraska and New York.
Specialties and state licenses
- Hematology and oncology, NebraskaPrimary
- New York license
Hematologists and oncologists near Dr. Schwarz
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. James Kendel Schwarz billed Medicare for 3,090 services in 2024
CMS data shows 3,090 Medicare services from Dr. Schwarz across 20 procedure codes in 2024, for 198 Medicare patients. Medicare paid $64,029 for them.
Medicare services, 20243,090
Medicare patients198
Paid by Medicare$64,029
Procedure codes20
Dr. Schwarz's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 7,9852024: 1,90976%
- Tests and treatments
- 2023: 7162024: 83216%
- Office and hospital visits
- 2023: 3932024: 34911%
- Other services
- 2023: 14,7902024: 0100%
Where Dr. Schwarz's Medicare services took place, 2024
- In an office3,076100%
- In a facility140%
Dr. Schwarz compared with the Nebraska median for hematologists and oncologists, 2024
- Dr. Schwarz
- Nebraska median
- Medicare services
- 3,090vs 1,3222.3 times
- Medicare patients
- 198vs 40851% below
- Part D claims
- 249vs 54955% below
Medians across 79 hematologists and oncologists in Nebraska with Dmand AI profiles that report each measure.
Dr. Schwarz's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Schwarz?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Schwarz and other hematologists and oncologists in Nebraska.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. James Kendel Schwarz treated 198 Medicare patients in 2024, average age 75
CMS counts 198 Medicare patients who saw Dr. Schwarz in 2024. The largest group is 65 to 74, with 92 patients. 75% of them have high blood pressure, and 67% have high cholesterol. Their average risk score is 2.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Schwarz's median patient age at 67, with 59% women.
Medicare patients, 2024198
Average age75
Average risk score2.03
Dr. Schwarz's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Schwarz's Medicare patients by sex, 2024
- Women12061%
- Men7839%
Chronic conditions among Dr. Schwarz's Medicare patients, 2024
- High blood pressure75%
- High cholesterol67%
- Arthritis57%
- Cancer49%
- Ischemic heart disease36%
- Chronic kidney disease34%
- Diabetes28%
- Anxiety27%
Share of Medicare patients with each condition. A patient can have several.
Dr. Schwarz's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 67
Patient panel by sex, all payers
- Women59%
- Men41%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. James Kendel Schwarz wrote 450 Medicare Part D claims in 2024
In 2024, Dr. Schwarz wrote 450 Medicare Part D claims for 87 patients. 80% of them were for generic drugs. CMS names the drug for 249 of them, across 16 drugs with 11 or more claims each, at $568,841 in total drug cost. In 2023, CMS named 140 claims across 9 drugs.
Part D claims, 2024450
Drugs named by CMS16
Total drug cost$568,841
Part D patients87
Dr. Schwarz's Part D claims by kind of drug, 2024
- Generic361 claims80%
- Brand-name89 claims20%
Dr. Schwarz's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Schwarz's Part D claims, 2024
- Opioids9%40 of 450 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1402024: 24978%
Drugs named by CMS: 16 in 2024, 9 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. James Kendel Schwarz takes part in Medicare
Dr. Schwarz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Schwarz by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. James Kendel Schwarz has 5 publications on record
Dmand AI links 5 papers to Dr. Schwarz, published from 2014 to 2020. The most frequent topics are Antineoplastic Agents and Antineoplastic Combined Chemotherapy Protocols. Dr. Schwarz's most frequent co-authors are Vijaya Raj Bhatt, MD, Jean L. Grem, MD and Chandrakanth Are, MD.
Papers5
Years published2014 to 2020
Dr. Schwarz's papers by year, 2014 to 2020
Topics Dr. Schwarz writes about most
- Antineoplastic Agents
- Antineoplastic Combined Chemotherapy Protocols
Dr. Schwarz's most frequent co-authors
- Vijaya Raj Bhatt, MD2 shared papers
- Jean L. Grem, MD2 shared papers
- Chandrakanth Are, MD1 shared paper
Recent publications by Dr. Schwarz
AminopterinAntineoplastic AgentsCarcinoma, Non-Small-Cell Lung
J Natl Compr Canc Netw
Antineoplastic AgentsAntineoplastic Combined Chemotherapy Protocolsfms-Like Tyrosine Kinase 3
See who Dr. Schwarz researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Schwarz works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. James Kendel Schwarz has worked on 5 clinical trials
Dmand AI links Dr. Schwarz to 5 clinical trials, 2 of them phase 1/2 studies. Conditions studied include Carcinoma, Transitional Cell, Prostatic Neoplasms and Urethral Neoplasms.
Clinical trials with Dr. Schwarz by phase
- NonePhase 1: no trials
- 2Phase 1/2: 2 trials
- 2Phase 2: 2 trials
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Schwarz's trials
- Carcinoma, Transitional Cell
- Prostatic Neoplasms
- Urethral Neoplasms
- Urinary Bladder Neoplasms
- Carcinoma, Renal Cell
Investigators on the most trials with Dr. Schwarz
- Thomas W. Flaig, MD2 shared trials
- Noah M. Hahn, MD2 shared trials
- Frederick Edward Millard, MD2 shared trials
Recent clinical trials with Dr. Schwarz
Prostatic NeoplasmsProstatic DiseasesCyclophosphamideLenalidomide
Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine (opens in a new tab)
CompletedPhase 1/2
Carcinoma, Transitional CellCarcinoma, Renal CellGEN-009 Adjuvanted VaccineNivolumabPembrolizumab
Cisplatin and Gemcitabine Hydrochloride With or Without Berzosertib in Treating Patients With Metastatic Urothelial Cancer (opens in a new tab)
CompletedPhase 2
BerzosertibCisplatinGemcitabine Hydrochloride
A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer (opens in a new tab)
CompletedPhase 3
Urethral NeoplasmsUrethral DiseasesDocetaxelRamucirumab
S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer (opens in a new tab)
CompletedPhase 2
Urinary Bladder NeoplasmsUrinary Bladder DiseasesCisplatinDoxorubicinFilgrastim
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. James Kendel Schwarz received $2,977 in industry payments from 2016 to 2025
CMS Open Payments shows 159 general payments to Dr. Schwarz from 48 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $411.
General payments to Dr. Schwarz by program year, 2016 to 2025
Companies that paid Dr. Schwarz the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. James Kendel Schwarz graduated from Duke University School of Medicine
Dr. Schwarz graduated from Duke University School of Medicine in 1983.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. James Kendel Schwarz's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. James Kendel Schwarz
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. James Kendel Schwarz's NPI number?
Dr. James Kendel Schwarz's NPI number is 1710968847. It was assigned on November 7, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. James Kendel Schwarz?
Dr. James Kendel Schwarz is a hematologist and oncologist in Omaha, Nebraska. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. James Kendel Schwarz practice?
Dr. Schwarz practices at 8303 Dodge St, Omaha, NE 68114. Dr. Schwarz's primary practice is Nebraska Methodist Hospital in Omaha, Nebraska. Dmand AI also links Dr. Schwarz to 1 hospital and 1 medical group.
What is Dr. James Kendel Schwarz's office phone number?
The practice phone on file for Dr. Schwarz is (402) 354-4000.
What is Dr. James Kendel Schwarz's medical license number?
Dr. Schwarz holds Nebraska license 24854, one of the licenses on file in 2 states.
Which states has Dr. James Kendel Schwarz been licensed in?
Dmand AI has state licenses on file for Dr. Schwarz in Nebraska and New York.
Which hospitals is Dr. James Kendel Schwarz affiliated with?
Dr. Schwarz is affiliated with Methodist Hospital. Dmand AI links Dr. Schwarz to 1 more hospital.
What medical group is Dr. James Kendel Schwarz part of?
Dr. Schwarz is linked to Nebraska Cancer Specialists. Dmand AI links Dr. Schwarz to 1 more medical group.
Does Dr. James Kendel Schwarz accept Medicare?
Yes. CMS data shows Dr. Schwarz billed Medicare for 3,090 services in 2024, and Dr. Schwarz accepts Medicare assignment.
How many Medicare patients does Dr. James Kendel Schwarz see?
CMS counts 198 Medicare patients who saw Dr. Schwarz in 2024, with an average age of 75.
Show 7 more questionsShow fewer questions
What services does Dr. James Kendel Schwarz bill to Medicare?
In 2024, Dr. Schwarz's most billed Medicare services were injected or infused drug (J2469), injected or infused drug (J1100) and injected or infused drug (J7050).
Where did Dr. James Kendel Schwarz go to medical school?
Dr. Schwarz graduated from Duke University School of Medicine in 1983.
What drugs does Dr. James Kendel Schwarz prescribe most?
In 2024 Medicare Part D data, Dr. Schwarz's most prescribed drugs by claims were Levothyroxine Sodium, Ondansetron HCl and Prednisone.
Has Dr. James Kendel Schwarz received payments from drug or device companies?
CMS Open Payments shows $2,977 in general payments to Dr. Schwarz from 48 companies from 2016 to 2025. The largest total came from Bristol-Myers Squibb Company.
How long has Dr. James Kendel Schwarz been practicing?
Dr. Schwarz graduated from medical school in 1983, 43 years ago.
Does Dr. James Kendel Schwarz do research?
Dmand AI links 5 publications to Dr. Schwarz, published from 2014 to 2020. Dr. Schwarz has worked on 5 clinical trials.
Who does Dr. James Kendel Schwarz publish with?
Dr. Schwarz's most frequent co-authors are Vijaya Raj Bhatt, MD (2 shared papers), Jean L. Grem, MD (2 shared papers) and Chandrakanth Are, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in Nebraska by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card